A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1

NCT01185860 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: danoprevir
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: placebo
DRUG: ribavirin
DRUG: ritonavir

Sponsor

Hoffmann-La Roche